Evaluation of the Integrity of the Dopamine System in a Rodent Model of Parkinson’s Disease: Small Animal Positron Emission Tomography Compared to Behavioral Assessment and Autoradiography
暂无分享,去创建一个
Doris J. Doudet | Vesna Sossi | V. Sossi | I. Cepeda | D. Doudet | Elissa M. Strome | Ivan L. Cepeda | E. Strome
[1] S J Kish,et al. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self- administration , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[2] P. Bickford,et al. Effects of intra-striatal GDNF on motor coordination and striatal electrophysiology in aged F344 rats☆ , 2000, Neurobiology of Aging.
[3] Jean Logan,et al. Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] J C Mazziotta,et al. Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.
[5] T. Schallert,et al. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury , 2000, Neuropharmacology.
[6] M R Kilbourn,et al. A simple synthesis of [11C]dihydrotetrabenazine (DTBZ). , 1997, Nuclear medicine and biology.
[7] M. Beu,et al. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] U. Ungerstedt,et al. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.
[9] Simon R Cherry,et al. Evaluation of a stereotactic frame for repositioning of the rat brain in serial positron emission tomography imaging studies , 2001, Journal of Neuroscience Methods.
[10] Michael E. Phelps,et al. Quantitation in Positron Emission Computed Tomography , 1980 .
[11] S. Cherry,et al. MicroPET II: design, development and initial performance of an improved microPET scanner for small-animal imaging. , 2003, Physics in medicine and biology.
[12] I. Q. Wishaw,et al. THE BEHAVIOR OF THE LABORATORY RAT A Handbook with Tests , 2004 .
[13] Masaaki Tanaka,et al. Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography , 2003, NeuroImage.
[14] R. N. Goble,et al. Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. , 2001, Physics in medicine and biology.
[15] D. Doudet,et al. Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands: the effects of chronic desipramine treatment on serotonin 5-HT2 receptors , 2005, Journal of Neuroscience Methods.
[16] J. Mazziotta,et al. TOMOGRAPHIC MAPPING OF HUMAN CEREBRAL METABOLISM: NORMAL UNSTIMULATED STATE , 1981 .
[17] H. Onoe,et al. Difference in response of D2 receptor binding between11C-N-methylspiperone and11C-raclopride against anesthetics in rhesus monkey brain , 2005, Journal of Neural Transmission / General Section JNT.
[18] D Hell,et al. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. , 2000, Journal of psychiatric research.
[19] Takashi Kato,et al. Rat‐PET study without anesthesia: Anesthetics modify the dopamine D1 receptor binding in rat brain , 2004, Synapse.
[20] S R Cherry,et al. Quantitative Assessment of Longitudinal Metabolic Changes In Vivo after Traumatic Brain Injury in the Adult Rat using FDG-MicroPET , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] B. Costall,et al. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. , 1976, European journal of pharmacology.
[22] S. Walsh,et al. Motor impairments after methamphetamine-induced neurotoxicity in the rat. , 1992, The Journal of pharmacology and experimental therapeutics.
[23] J. Wamsley,et al. Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain , 1995, Journal of Chemical Neuroanatomy.
[24] D. M. Feeney,et al. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. , 1982, Science.
[25] T. Schallert,et al. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury , 2005, Behavioural Brain Research.
[26] R. N. Goble,et al. Performance evaluation of the microPET R4 PET scanner for rodents , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[27] M. Kilbourn,et al. Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site. , 1992, European journal of pharmacology.
[28] V. Sossi,et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease , 2000, Annals of neurology.
[29] R. Leahy,et al. Optimization and performance evaluation of the microPET II scanner for in vivo small-animal imaging , 2004, Physics in medicine and biology.
[30] A. Norman,et al. Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum , 1993, Pharmacology Biochemistry and Behavior.
[31] D. Scherman,et al. [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum , 1990, Neuroscience Letters.
[32] T. Reader,et al. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies , 1997, Neurochemistry International.
[33] J. Holden,et al. Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP‐treated monkeys: PET studies with [11C]raclopride , 2002, Synapse.
[34] G. Di Chiara,et al. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. , 1989, European journal of pharmacology.
[35] K. Frey,et al. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. , 1995, European journal of pharmacology.
[36] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[37] S. Kish,et al. The Vesicular Monoamine Transporter, in Contrast to the Dopamine Transporter, Is Not Altered by Chronic Cocaine Self-Administration in the Rat , 1996, The Journal of Neuroscience.
[38] S. Siegel,et al. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] K. Frey,et al. Imaging of monoaminergic and cholinergic vesicular transporters in the brain. , 1998, Advances in pharmacology.
[40] Ulla Ruotsalainen,et al. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride , 1995, Journal of the Neurological Sciences.
[41] D. Scherman,et al. Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin , 1989, Neuroscience.
[42] H. Müller-Gärtner,et al. Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.